CORRECTED: Part Of Crestor Case Moves To Fla.

By Hilary Russ

Law360, New York (February 19, 2010, 6:59 PM ET) -- Despite objections from plaintiff AstraZeneca Pharmaceuticals LP, a federal judge has adopted a magistrate judge's ruling that the drugmaker's patent infringement lawsuit against one defendant, Apotex Inc., over the cholesterol medication Crestor should be moved to Florida.

Judge Joseph J. Farnan Jr. of U.S. District Court for the District of Delaware said on Friday that he agreed with a Dec. 11 report finding that the Delaware court lacked personal jurisdiction over Apotex and that claims against the defendant should be transferred to the U.S. District Court...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles